Sun Pharmaceutical Industries Ltd. | SUNPHARMA | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 72,756 | 64,876 | 64,455 | 50,334 | 57,703 |
Short-term investment |
| 39,507 | 48,974 | 31,301 | 76,339 | 93,726 |
Accounts receivables |
| 88,842 | 94,212 | 90,614 | 104,846 | 114,385 |
Inventories |
| 78,860 | 78,750 | 89,970 | 89,251 | 105,131 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 30,727 | 29,730 | 28,081 | 27,876 | 27,675 |
Total current assets |
| 310,692 | 316,542 | 304,421 | 348,646 | 398,619 |
Gross property plant... |
| 100,274 | 105,674 | 102,350 | 103,714 | 103,904 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 100,274 | 105,674 | 102,350 | 103,714 | 103,904 |
Work in Progress |
| 9,108 | 6,589 | 9,365 | 7,975 | 9,634 |
Miscellaneous Investment |
| 40,476 | 53,514 | 65,789 | 53,413 | 56,448 |
Deferred income taxes |
| 58,210 | 65,595 | 69,892 | 53,611 | 54,712 |
Intangible assets |
| 63,537 | 63,595 | 56,607 | 61,918 | 93,268 |
Goodwill |
| 59,558 | 64,815 | 62,876 | 65,913 | 87,127 |
Other long-term assets |
| 5,084 | 6,201 | 5,367 | 2,888 | 3,724 |
Total non-current assets |
| 336,246 | 365,983 | 372,247 | 349,432 | 408,817 |
Total assets |
| 646,938 | 682,525 | 676,667 | 698,078 | 807,436 |
Short-term debt |
| 83,708 | 55,494 | 24,449 | 7,008 | 61,979 |
Accounts Payable... |
| 41,479 | 40,937 | 39,737 | 44,898 | 56,815 |
Provisions |
| 29,323 | 39,702 | 45,827 | 91,478 | 53,544 |
Taxes Payable |
| 1,269 | 2,020 | 1,791 | 1,756 | 3,087 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 1,078 | 1,281 |
Other current liabilities |
| 17,617 | 18,911 | 49,653 | 25,867 | 22,364 |
Total current liabilities |
| 173,396 | 157,064 | 161,456 | 172,085 | 199,070 |
Long-term debt |
| 15,226 | 20,289 | 8,981 | 2,299 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 1,043 | 581 | 445 | 319 | 317 |
Provisions |
| 4,304 | 5,110 | 3,271 | 3,691 | 3,429 |
Capital Leases |
| 0 | 0 | 0 | 2,518 | 5,599 |
Other longterm liabilities |
| 5,743 | 8,233 | 7,715 | 6,506 | 5,866 |
Total non-current liabilities |
| 26,316 | 34,213 | 20,413 | 15,332 | 15,211 |
Total liabilities |
| 199,712 | 191,278 | 181,869 | 187,417 | 214,281 |
Share Capital |
| 2,399 | 2,399 | 2,399 | 2,399 | 2,399 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 411,691 | 450,245 | 462,229 | 477,713 | 557,555 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 33,135 | 38,602 | 30,171 | 30,549 | 33,201 |
Total Equity |
| 447,226 | 491,247 | 494,798 | 510,661 | 593,155 |
Total Liabilities and Equity |
| 646,938 | 682,525 | 676,667 | 698,078 | 807,436 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |